EXHIBIT 10.1 RESEARCH COLLABORATION AGREEMENT BETWEEN THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK AND B TWELVE LTD. AGREEMENT made this 19 day of August 1999 by and between THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, a...Research Collaboration Agreement • September 20th, 2005 • Kyto Biopharma Inc • Pharmaceutical preparations • New York
Research Collaboration Agreement For an Investigator Initiated ProjectResearch Collaboration Agreement • February 19th, 2024
This Agreement is based on the Alfred Health Research Collaboration Agreement for an Investigator Initiated Project.
Research Collaboration AgreementResearch Collaboration Agreement • November 21st, 2023 • Victoria
The Parties have agreed to collaborate on the Project in accordance with the terms and conditions set out in this Agreement.
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • October 28th, 2022 • Georgia
THIS AGREEMENT (“Agreement”) is made and entered into as of the date of last signature below (hereinafter “Effective Date”) by and between __________________________, a [Limited Liability Company, Corporation] organized under the laws of the state of ___________ and having offices at _________________________________ (“Sponsor”) and EMORY UNIVERSITY, a Georgia non-profit corporation with offices located at 1599 Clifton Road NE, 4th Floor, Mailstop 1599/001/1AZ, Atlanta, Georgia 30322 ( “Emory”).
South Dakota State University Technology Transfer Office DRAFT for Discussion purposes only. The terms offered in this draft expires thirty (30) days from the date of receipt RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • May 5th, 2020 • South Dakota
This Research Collaboration Agreement (the “Agreement”) is made by and between South Dakota State University, a public land grant university with its principal place of business at Box 2201, SAD 200, Brookings, South Dakota 57007-0291, (“SDSU”) and_______________, a _____________ corporation with its principal place of business at ________________________ (“XXX”) (collectively the “Parties” or individually the “Party”).
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • January 5th, 2024 • ArriVent Biopharma, Inc. • Pharmaceutical preparations • New York
This RESEARCH COLLABORATION AGREEMENT (the “Agreement”) is effective as of December 21, 2021 (the “Effective Date”) by and between Aarvik Therapeutics, Inc., a company incorporated in Delaware, having a place of business at 31363 Medallion Drive, Hayward, CA 94544 (“Aarvik”), and ArriVent Biopharma, Inc., a company incorporated in Delaware, with offices located at 18 Campus Blvd. Suite 100, Newtown Square, PA 19073-3269 (“ArriVent”). ArriVent and Aarvik are referred to herein individually, as a “Party” or, collectively, as “Parties.”
Research Collaboration AgreementResearch Collaboration Agreement • September 4th, 2024
(Name of the institute-XYZ) a statutory body constituted under the …………………. Act, functioning at its premises at ………….Address of the institution………… represented by the Dean,….. duly authorized by the Director, XYZ hereinafter referred to as ‘XYZ’ which expression shall where the context so admits includes its successors in interest and permitted assigns as First Party.
Research collaboration agreementResearch Collaboration Agreement • August 1st, 2020 • Victoria
To be used for short term, simple collaborations, without payments or material transfer between the parties. For agreements where significant amounts of equipment and payments (including valuable “in-kind” contributions are required) use a more detailed template. Do not use this agreement for NHMRC collaborations
Research Collaboration Agreement GuidelinesResearch Collaboration Agreement • August 17th, 2018
This Research Collaboration Agreement template is intended for investigator-initiated collaborative research projects. It has been pre-approved by all Monash Partners member organisations for these projects provided that the guidelines below are followed, the agreement is completed correctly and the legal terms are not modified except for amendments allowed by the guidelines. In these circumstances, no legal review will be required and the member organisations aim for expeditious approval in five business days or less.
RESEARCH COLLABORATION AGREEMENT BETWEEN CYTOMX THERAPEUTICS, INC. AND IMMUNOGEN, INC. JANUARY 8, 2014Research Collaboration Agreement • October 2nd, 2015 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • New York
This Research Collaboration and License Agreement (the “Agreement”) is entered into as of 1 (the “Effective Date”), by and between CytomX Therapeutics, Inc., a corporation organized and existing under the laws of Delaware and having a place of business at 343 Oyster Point Blvd., Suite 100, South San Francisco, California, 94080 United States (“CytomX”) and ImmunoGen, Inc., a corporation organized and existing under the laws of Massachusetts and having a place of business at 830 Winter Street, Waltham, Massachusetts, 02451 (“ImmunoGen”). CytomX and ImmunoGen may each be referred to herein individually as a “Party” and collectively as the “Parties.”
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • September 10th, 2015 • Gensight Biologics S.A. • Biological products, (no disgnostic substances) • Basel-Stadt
This Research Collaboration Agreement (the “Agreement”) having an Effective Date of March 1st, 2014, is made between the Friedrich Miescher Institute for Biomedical Research (“FMI”) located at Maulbeerstrasse 66, 4058 Basel, Switzerland, (Principal Investigator Dr. Botond Roska), and GenSight Biologics, located at 89 Rue du Fbg Saint Antoine, 75011 Paris, France (“GenSight”), (Principal Investigator Dr. Didier Pruneau), under the following terms and conditions.
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • October 12th, 2020 • Victoria
<Collaborator and institution> has agreed to collaborate on the research project on the terms and conditions set out in this Agreement.
RESEARCH COLLABORATION AGREEMENT BETWEENResearch Collaboration Agreement • October 26th, 2023
UNIVERSITI SAINS MALAYSIA, a public institution of higher learning established under the Universities and University Colleges Act 1971, which for the purpose of this Agreement is represented by its ***, with its main address at Level 6, Chancellery Building, Universiti Sains Malaysia, 11800 USM, Pulau Pinang, Malaysia (hereinafter referred to as “USM”) of the first part;
Howard Hughes Medical Institute Host-Based Model Research Collaboration AgreementResearch Collaboration Agreement • July 19th, 2017
This Research Collaboration Agreement (the “Agreement”), having an Effective Date of _________________, is made between [Company] (the “Company”), and Howard Hughes Medical Institute (“HHMI”) and [Host Institution] (the [“University/Hospital”]) under the following terms and conditions. HHMI and the [University/Hospital] are referred to collectively in this Agreement as the “Institutions” and, unless specifically named, are treated as a single party.
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • May 5th, 2020 • District of Columbia
This Agreement is between the Centers for Disease Control and Prevention (“CDC”), an agency of the U.S. Department of Health and Human Services, having offices located at 1600 Clifton Road, Atlanta, Georgia 30333, and , having a principal place of business at (“Collaborator”), (individually, a “Party”; collectively, the “Parties”).
Research Collaboration AgreementResearch Collaboration Agreement • February 18th, 2021 • New South Wales
Parties Macquarie University ABN 90 952 801 237 of North Ryde, NSW 2109 (Macquarie) Royal Prince Alfred Hospital ABN / ACN 17 520 269 052 of 50 Missenden Rd, Camperdown, NSW (Collaborating Organisation)
COGS 402 Research Collaboration AgreementResearch Collaboration Agreement • March 9th, 2019
COGS 402 is a capstone research course that enables students to exercise their skills and knowledge of computer science, linguistics, philosophy, and psychology, by gaining first-hand experience of cutting edge research that draws on one or more of these disciplines.
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • September 18th, 2019 • District of Columbia
This Agreement is between the National Center for Advancing Translational Sciences (“NCATS”), which is a component of the National Institutes of Health (“NIH”), an agency of the U.S. Department of Health and Human Services, having offices located at 9800, Medical Center Drive, Rockville, MD 20850, and COLLABORATOR (“Collaborator”), having a principal place of business at ADDRESS (collectively, the “Parties”). This Agreement is neither a funding agreement as defined in 35 U.S.C. § 201(b) nor a cooperative research and development agreement authorized under the Federal Technology Transfer Act of 1986, as amended, 15 U.S.C. §§ 3710a et seq., and Executive Order 12591 of April 10, 1987. NCATS enters into this Agreement pursuant to the authority of the Public Health Services Act of 1944, as amended (42 U.S.C. § 241).
ARTICLE 1. DEFINITIONSResearch Collaboration Agreement • January 8th, 2001 • Third Wave Technologies Inc /Wi • Biological products, (no disgnostic substances) • California
ANDResearch Collaboration Agreement • July 20th, 2000 • Gemini Genomics PLC • Services-commercial physical & biological research • New York
RESEARCH COLLABORATION AGREEMENT BETWEENResearch Collaboration Agreement • January 16th, 2017
UNIVERSITI SAINS MALAYSIA, a public institution of higher learning established under the Universities and University Colleges Act 1971, which for the purpose of this Agreement is represented by the ____________________________, with its main campus at 11800 USM, Pulau Pinang (hereinafter referred to as “USM”) of the first part;
RESEARCH COLLABORATION AGREEMENT — INVENTIONS AND MATERIALS —Research Collaboration Agreement • March 30th, 2006 • Mfic Corp • Laboratory apparatus & furniture • Massachusetts
This Agreement, effective as of September 21, 2005 (the “Effective Date”), is between the University of Massachusetts Lowell (“UML” or “Institution”), a public institution of higher education of the Commonwealth of Massachusetts, and MFIC Corporation, a Delaware corporation (“Sponsor”),
EX-10.4 3 a05-21212_4ex10d4.htm MATERIAL CONTRACTS AERES Biomedical Ltd. Lpath Therapeutics, Inc. ****CONFIDENTIAL PORTIONS OF THIS AGREEMENT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL...Research Collaboration Agreement • May 5th, 2020 • England
This Research Collaboration Agreement is (“Agreement”) entered into and effective this day of August, 2005 (hereinafter the “Effective Date”), by and between
Unfunded Research Collaboration Agreement With Non-Profit (With Material Transfer)Research Collaboration Agreement • January 30th, 2024 • Minnesota
This Research Collaboration Agreement (the “Agreement”), effective as of , (the “Effective Date”), is entered into by and between the Regents of the University of Minnesota, a Minnesota constitutional corporation, through its Office of Sponsored Projects Administration(“University), and , (“Non-Profit Entity”). University and Non-Profit Entity each shall be referred to herein as a “Party” and together as the “Parties.”
ContractResearch Collaboration Agreement • November 22nd, 2018
Agreement between 18F-Florbetapir PET imaging and cerebrospinal fluid Aβ1-42, Aβ1-40, tTau and pTau measured on the LUMIPULSE G fully automated platform
February 22, 2022Research Collaboration Agreement • November 2nd, 2022
Actinium Pharmaceuticals, Inc. and AVEO Oncology Enter Research Collaboration Agreement to Develop First-in-Class Actinium-225 ErbB3 Targeting Radiotherapy for Solid Tumors
Research Collaboration Agreement GuidelinesResearch Collaboration Agreement • February 20th, 2024
This Research Collaboration Agreement template is intended for investigator-initiated collaborative research projects. It has been pre-approved by all Monash Partners member organisations for these projects provided that the guidelines below are followed, the agreement is completed correctly and the legal terms are not modified except for amendments allowed by the guidelines. In these circumstances, no legal review will be required and the member organisations aim for expeditious approval in five business days or less.
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • September 29th, 2023 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Research Collaboration Agreement (this “Agreement”), effective as of February 3, 2021 (the “Effective Date”), is entered into by and between Cornell University, for and on behalf of its Joan & Sanford I. Weill Medical College, a New York education corporation with offices at 1300 York Avenue, New York, NY 10065 (“WCM”), and LEXEO Therapeutics, Inc., a Delaware corporation, having an office at 430 East 29th Street, 14th Floor, New York, NY 10016 (“Company”). WCM and Company each may be referred to herein as a “Party” and together as the “Parties.”
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • July 9th, 2012 • Stellar Biotechnologies, Inc. • Pharmaceutical preparations
STELLAR BIOTECHNOLOGIES, Inc., a corporation duly organized under and pursuant to the laws of California, USA, and having its principal offices at 321E. Hueneme Rd, #170 Port Hueneme, CA 93041, USA, (hereinafter referred to as “STELLAR”)
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • March 8th, 2023
Singapore Sports Council, a body corporate established under the Singapore Sports Council Act and having its principal place of business at 3 Stadium Drive, Singapore 397630 (rebranded as “Sport Singapore” with effect from 1 April 2014 and hereinafter referred to as “SportSG” or “Sport Singapore”).
LOGO หน่วยงาน Research Collaboration Agreement On the project entitled …..…..…..…..…..….. between Mahidol University (….Faculty / Institute ….) and (Name of Organization …..…..…..…..…..…..…..…..)Research Collaboration Agreement • January 27th, 2020
This Research Collaboration Agreement (hereinafter referred to as “Agreement”) is made at Mahidol University as of …..…..…..…..…..…..(date) by and between:
2 3 RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • February 20th, 1997 • Ilex Oncology Inc • Services-medical laboratories • York
Enhancing the Health, Fitness and Performance of UK Firefighters: an Interim ReportResearch Collaboration Agreement • May 6th, 2014
This programme of work, led by the University of Bath, was commissioned by the Chief Fire Officer’s Association (CFOA), with financial support from the Fire Service Research and Training Trust (FSRTT) and the FireFit Steering Group (FFSG). The project has been guided by a ‘Stakeholder Panel’, with invitees from the Chief Fire Officer’s Association (CFOA), the Fire Brigade’s Union (FBU), the Retained Fire Brigade’s Union (RFBU), as well as the FRS health and fitness community. Any representatives of these groups who did not attend meetings were kept updated separately. The initial phase of research, reported here, had three clear aims:
INDUSTRY RESEARCH COLLABORATION AGREEMENT RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • November 24th, 2023 • Cuprina Holdings (Cayman) LTD • Pharmaceutical preparations
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • March 19th, 2004 • Micromem Technologies Inc • Services-computer programming services • Ontario
WHEREAS the Researcher is employed by the University as a professor and principal investigator and is entitled to participate in research projects funded in whole or in part by MMO in accordance with the terms of the University Collaboration Agreement between MMO and the University effective as of January 1, 1998, (the University Collaboration Agreement).
